EP 2268307 A1 20110105 - VACCINE
Title (en)
VACCINE
Title (de)
IMPFSTOFF
Title (fr)
VACCIN
Publication
Application
Priority
- EP 2009054492 W 20090416
- US 4529208 P 20080416
Abstract (en)
[origin: WO2009127677A1] The present invention provides an immunogenic composition comprising an antigen or antigen composition and an adjuvant composition comprising an oil in water emulsion, wherein said oil in water emulsion comprises 0.5 - 10 mg metabolisable oil, 0.5 - 11 mg tocol and 0.1 - 4 mg emulsifying agent, per human dose.
IPC 8 full level
A61K 39/085 (2006.01); A61K 39/145 (2006.01); A61K 39/295 (2006.01); A61K 39/39 (2006.01)
CPC (source: EP US)
A61K 39/39 (2013.01 - EP US); A61P 31/04 (2018.01 - EP); A61P 37/04 (2018.01 - EP); A61K 2039/55566 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA RS
DOCDB simple family (publication)
WO 2009127677 A1 20091022; AU 2009237648 A1 20091022; BR PI0910884 A2 20151006; CA 2720877 A1 20091022; CN 102065889 A 20110518; EA 201001478 A1 20110630; EP 2268307 A1 20110105; IL 208652 A0 20101230; JP 2011516597 A 20110526; KR 20110009158 A 20110127; MX 2010011393 A 20101109; US 2011189223 A1 20110804; ZA 201007402 B 20140326
DOCDB simple family (application)
EP 2009054492 W 20090416; AU 2009237648 A 20090416; BR PI0910884 A 20090416; CA 2720877 A 20090416; CN 200980123420 A 20090416; EA 201001478 A 20090416; EP 09733652 A 20090416; IL 20865210 A 20101012; JP 2011504456 A 20090416; KR 20107025695 A 20090416; MX 2010011393 A 20090416; US 93788009 A 20090416; ZA 201007402 A 20101015